Stereotaxis (STXS) Shares Outstanding (Weighted Average) (2010 - 2026)
Stereotaxis (STXS) reported Shares Outstanding (Weighted Average) of $98.9 million for Q1 2026, up 12.67% year-over-year from $87.8 million in Q1 2025, and up 8.72% quarter-over-quarter from $91.0 million in Q4 2025.
Stereotaxis (STXS) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $98.9 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $98.9 million, up 12.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.9 million (up 12.67% YoY), and the FY2025 annual result was $91.0 million, up 6.78% from the prior year.
- Shares Outstanding (Weighted Average) grew to $98.9 million in Q1 2026 per STXS's latest filing, from $91.0 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $98.9 million in Q1 2026 and troughed at $75.9 million in Q1 2022.
- A 5-year average of $83.1 million and a median of $83.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) rose 0.66% in 2022, then increased 12.67% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $76.1 million in 2022, then advanced by 6.1% to $80.7 million in 2023, then rose by 5.55% to $85.2 million in 2024, then increased by 6.78% to $91.0 million in 2025, then advanced by 8.72% to $98.9 million in 2026.
- Business Quant data shows STXS's Shares Outstanding (Weighted Average) at $98.9 million in Q1 2026, $91.0 million in Q4 2025, and $89.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | 98.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.89 Mn |
| Dec 31, 2025 | 90.96 Mn |
| Sep 30, 2025 | 89.26 Mn |
| Jun 30, 2025 | 87.86 Mn |
| Mar 31, 2025 | 87.77 Mn |
| Dec 31, 2024 | 85.18 Mn |
| Sep 30, 2024 | 84.63 Mn |
| Jun 30, 2024 | 84.03 Mn |
| Mar 31, 2024 | 83.48 Mn |
| Dec 31, 2023 | 80.70 Mn |
| Sep 30, 2023 | 80.03 Mn |
| Jun 30, 2023 | 78.79 Mn |
| Mar 31, 2023 | 76.50 Mn |
| Dec 31, 2022 | 76.06 Mn |
| Sep 30, 2022 | 75.98 Mn |
| Jun 30, 2022 | 75.92 Mn |
| Mar 31, 2022 | 75.88 Mn |
| Dec 31, 2021 | 75.56 Mn |
| Sep 30, 2021 | 75.48 Mn |
| Jun 30, 2021 | 75.36 Mn |